Vibrant has secured €4 million in seed round funding. The funding will be used use the funding to grow its customer base and prioritize extensions into new markets.
Livv revolutionizes healthcare by consolidating fragmented medical records into a single, accessible platform, enabling better patient care through comprehensive health data and improved doctor-patient communication.
In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.
Unveiling sustainable end-of-life solutions with MEINE ERDE, transforming death care to honor environmental values and personal dignity.